NSE filing, NSE: SUMIT. Summary written from the filing by ALFA Finder's alert engine.
Sumit Woods Ltd: key numbers
- Share price
- ₹45.00
- Market cap
- ₹215.4 Cr
- Revenue (annual)
- ₹94.88 Cr
- Net profit (annual)
- ₹6.06 Cr
- P/E (TTM)
- 32.3×Sector 34.0×
- Promoter holding
- 60.85%+0.00% QoQ
- FII holding
- 0.02%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sumit Woods Ltd
All →Sumit Woods Board Meeting Date
Sumit Woods has scheduled a board meeting on 04-Nov-2026 to consider unaudited half-yearly financial results for September 2026. The trading window remains closed until 07-Nov-2026.
Sumit Woods Annual General Meeting
Sumit Woods Limited conducted its 30th Annual General Meeting on September 03, 2026. The meeting covered ordinary and special business resolutions through video conferencing.
Sumit Woods Capacity Expansion: ₹85 Cr Investment
Sumit Woods received an Intimation of Disapproval (IOD) for the Makwana Building redevelopment project in Vile Parle, Mumbai, with an estimated gross development value of Rs. 85 Crore.
- Value
- ₹85.00 Cr
Sumit Woods Merger & Restructuring Worth ₹0.01 Cr
Sumit Woods Limited is acquiring a 99% stake in Arcstone Capital Management LLP for ₹0.01 Crore. This investment supports the Company's strategic management and advisory activities.
- Value
- ₹0.01 Cr
Sumit Woods Annual General Meeting
Sumit Woods Limited has scheduled its 30th Annual General Meeting for September 3rd, 2026. The company will close its share transfer books from August 28th to September 3rd, 2026.
Sumit Woods Business Update
Sumit Woods Ltd. received an Intimation of Disapproval (IOD) from the BMC for the redevelopment of the Vidyavihar Co-op Housing Society project.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.